LAI GOLDMAN MYLA bought QTRX
July 8, 2025 · Form 4 insider transaction
LAI GOLDMAN MYLA bought 2,940 shares of Quanterix Corporation, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,940
Price
N/A
Total value
N/A
InsiderLAI GOLDMAN MYLA
RoleDirector
CompanyQuanterix Corporation (QTRX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 8, 2025
Filing dateJuly 10, 2025
Shares owned after2,940
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Received in exchange for 20,000 shares of Akoya Biosciences, Inc. ("Akoya") common stock in connection with the acquisition of Akoya by Quanterix on July 8, 2025. Dr. Lai-Goldman received: (a) 0.1470 of a share of Quanterix common stock and (b) $0.37 in cash, for each share of Akoya common stock. The closing price of the Quanterix common stock on July 8, 2025 was $6.54 per share. The closing price of the Akoya common stock on July 7, 2025 was $1.29 per share.